Aims: To determine the relationship between Lgr5 and other stemness markers and pathologic features in pancreatic ductal adenocarcinoma (PDAC) samples. Materials & methods: In 69 samples, Lgr5 was analyzed by qRT-PCR together with a panel of 29 genes. Bioinformatic analysis was carried out to identify a possible pathway regulating Lgr5 expression in PDAC. Results: Lgr5 expression was not associated with the expression of tested cancer stem cell markers. Moreover, it was not an independent predictor of survival neither at univariate analysis (p = 0.21) nor at multivariate analysis (p = 0.225). Conclusion: Based on the lack of correlation between Lgr5 and tested cancer stem cell markers, Lgr5 does not seem to be a potential stemness marker or prognostic factor in PDAC.

Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses / K. Andrikou, M. Santoni, F. Piva, A. Bittoni, A. Lanese, C. Pellei, A. Conti, C. Loretelli, A. Mandolesi, M. Giulietti, M. Scarpelli, G. Principato, M. Falconi, S. Cascinu. - In: FUTURE ONCOLOGY. - ISSN 1479-6694. - 11:7(2015 Apr 01), pp. 1037-1045. [10.2217/fon.15.27]

Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses

C. Loretelli;
2015

Abstract

Aims: To determine the relationship between Lgr5 and other stemness markers and pathologic features in pancreatic ductal adenocarcinoma (PDAC) samples. Materials & methods: In 69 samples, Lgr5 was analyzed by qRT-PCR together with a panel of 29 genes. Bioinformatic analysis was carried out to identify a possible pathway regulating Lgr5 expression in PDAC. Results: Lgr5 expression was not associated with the expression of tested cancer stem cell markers. Moreover, it was not an independent predictor of survival neither at univariate analysis (p = 0.21) nor at multivariate analysis (p = 0.225). Conclusion: Based on the lack of correlation between Lgr5 and tested cancer stem cell markers, Lgr5 does not seem to be a potential stemness marker or prognostic factor in PDAC.
cancer stem cell; embryonic signaling pathways; Lgr5; overall survival; pancreatic ductal adenocarcinoma; adenocarcinoma; aged; aged, 80 and over; biomarkers, tumor; carcinoma, pancreatic ductal; female; humans; male; middle aged; neoplastic stem cells; pancreatic neoplasms; real-time polymerase chain reaction; receptors, g-protein-coupled; oncology; cancer research
Settore MED/06 - Oncologia Medica
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
Settore BIO/13 - Biologia Applicata
Settore MED/04 - Patologia Generale
1-apr-2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
Lgr5 expression, cancer stem cells and pancreatic cancer_results from biological and computational analyses.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.21 MB
Formato Adobe PDF
1.21 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/570199
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact